BIOLASE Inc (NASDAQ:BIOL) Stock Is All Set To Gap-Up: Now What?

November 24, 2021

The premarket trading period is often a good time for investors to get a fair idea about the market and this morning, the BIOLASE Inc (NASDAQ:BIOL) stock could be the one to watch. Trading Data On Tuesday, BIOL stock fell 4.78% to $0.42 with 7.13 million shares, compared to its average volume of 2.03 million shares. The stock has moved within a range of $0.4150 – 0.4478 after opening trade…


BIOLASE Inc. (NASDAQ:BIOL) Stock Soars 35% in a Month: What’s The Buzz?

September 1, 2021

BIOLASE Inc. (NASDAQ:BIOL) is up 35% in a month. The company and Dr. L. Stephen Buchanan have announced a clinical advisory partnership to expand the adoption of lasers and enhanced hands-on training services with a leading endodontics player.  Buchanan has over 30 years of experience in teaching endodontic courses in dental schools and symposiums worldwide and at his ultramodern training facility DELabs in Santa Barbara, California. In addition, he is…


Biolase Inc (NASDAQ:BIOL) Stock Resumes Uptrend After The Recent Consolidation

August 24, 2021

Biolase Inc (NASDAQ:BIOL), which is one of the worldwide leaders in the field of dental lasers, has not been in the news for some days but that did not stop its stock from delivering considerable gains yesterday. Investors seemed to have taken a shine to the Biolase stock yesterday and consequently it ended the day with gains of as much as 15%. In light of such gains, it could be…


Biolase Inc (NASDAQ:BIOL) Stock Breakout Alert: How to Trade Now?

August 16, 2021

The premarket action in the market is often a pretty good indication on how the rest of the day might pan out and hence it could be a good move to take a closer look at the Biolase Inc (NASDAQ:BIOL) stock. The company was in the news last after it announced its financial results for the second fiscal quarter and on Friday, its stock has managed to clock gains of…


BIOLASE Inc. (NASDAQ:BIOL) Stock Is All Set To Gap Up: What’s The Buzz?

August 13, 2021

BIOLASE Inc. (NASDAQ:BIOL) is up 28% in premarket after announcing its Q2 2021 financial results for the quarter ended June 30, 2021, and provided Q3 2021 revenue guidance. The company reported YoY net revenue growth of 211% to $9.1 million, which was 6% more than pre-pandemic revenues in Q2 2019. BIOLASE’s laser system revenues were up 424%, while consumables and other sales were up 173%. In addition, international and US…